|
US4570630A
(en)
*
|
1983-08-03 |
1986-02-18 |
Miles Laboratories, Inc. |
Medicament inhalation device
|
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
GB9216038D0
(en)
*
|
1992-07-28 |
1992-09-09 |
Bespak Plc |
Dispensing apparatus for powdered medicaments
|
|
FI954098A7
(fi)
*
|
1993-03-03 |
1995-09-01 |
Tenax Corp |
Kuivajauheen inhalaattorin lääkeaineen kantolaite
|
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
|
US5505194A
(en)
*
|
1994-03-23 |
1996-04-09 |
Abbott Laboratories |
Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions
|
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
|
FR2731911B1
(fr)
*
|
1995-03-20 |
1997-08-14 |
Paul Seyvos |
Dispositif qui permet d'inhaler, par la bouche, l' odeur de produits contenus dans un reservoir a des fins therapeutiques
|
|
ES2216418T3
(es)
|
1995-12-07 |
2004-10-16 |
Jago Research Ag |
Boquilla para un inhalador para la administracion de varias dosis de un polvo seco farmacologico.
|
|
US7131441B1
(en)
|
1995-12-07 |
2006-11-07 |
Skyepharma Ag |
Inhaler for multiple dosed administration of a pharmacological dry powder
|
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
|
CA2212430A1
(fr)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Appareil inhalateur
|
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
|
DE29908593U1
(de)
|
1999-05-14 |
1999-07-22 |
Jago Research AG, Hergiswil |
Mundstück für einen Inhalator zur Abgabe eines Medikaments
|
|
NZ521034A
(en)
|
2000-02-28 |
2004-08-27 |
Vectura Ltd |
Improvements in or relating to the delivery of oral drugs
|
|
US6595210B2
(en)
*
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
|
GB2380410B
(en)
*
|
2001-10-05 |
2003-11-19 |
Alchemy Healthcare Ltd |
Apparatus for the nasal or oral delivery of a medicament
|
|
EP1483283A4
(fr)
|
2002-03-13 |
2007-04-11 |
Signum Biosciences Inc |
Modulation de la methylation de proteines et du phosphate des phosphoproteines
|
|
ITMO20020297A1
(it)
*
|
2002-10-16 |
2004-04-17 |
Roberto Oliva |
Inalatore per preparati monodose in capsule.
|
|
US20060045849A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Farhan Taghizadeh |
Method of customizing the fragrance of nasal medications
|
|
PL370285A1
(pl)
*
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
|
CA2601777A1
(fr)
|
2005-02-03 |
2006-08-10 |
Signum Biosciences, Inc. |
Compositions et procedes pour l'amelioration de la fonction cognitive
|
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
|
WO2007052154A2
(fr)
|
2005-04-29 |
2007-05-10 |
University Of Medicine And Dentistry Of New Jersey |
Peptide court derive d'erythropoietine et ses mimetiques utilises comme modulateurs immuno / inflammatoires
|
|
US9345745B2
(en)
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
|
WO2007024876A2
(fr)
*
|
2005-08-24 |
2007-03-01 |
The Board Of Trustees Of Leland Stanford Junior University |
Methodes de traitement et de surveillance de l'inflammation et du desequilibre d'oxydoreduction dans la mucoviscidose
|
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
|
US8716220B2
(en)
*
|
2005-09-07 |
2014-05-06 |
Nikolaos Tezapsidis |
Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amyloid beta
|
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
GB0604444D0
(en)
|
2006-03-06 |
2006-04-12 |
Optinose As |
Nasal devices
|
|
AU315527S
(en)
|
2006-09-28 |
2007-08-03 |
Glaxo Group Ltd |
Inhalation device
|
|
AU2007342674B2
(en)
*
|
2007-01-10 |
2013-09-19 |
Purdue Research Foundation |
Polypeptide inhibitors of HSP27 kinase and uses therefor
|
|
JP5703466B2
(ja)
*
|
2007-08-07 |
2015-04-22 |
パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ |
キナーゼ阻害薬およびその使用
|
|
US8757146B2
(en)
|
2008-02-07 |
2014-06-24 |
University Of Washington Through Its Center For Commercialization |
Circumferential aerosol device
|
|
CA2725143A1
(fr)
*
|
2008-05-21 |
2009-11-26 |
Neurotez, Inc. |
Procedes de traitement de troubles cognitifs progressifs lies a la degenerescence neurofibrillaire
|
|
ES2929343T3
(es)
*
|
2008-06-13 |
2022-11-28 |
Mannkind Corp |
Inhalador de polvo seco accionado por aspiración para la administración de fármacos
|
|
CN102256613B
(zh)
*
|
2008-10-20 |
2014-09-10 |
莫伊莱麦屈克斯公司 |
用于治疗或者预防粘连的多肽
|
|
CA2744104C
(fr)
*
|
2008-12-10 |
2017-07-18 |
Purdue Research Foundation |
Inhibiteur permeant cellulaire de kinases a base peptidique
|
|
EP2456772A4
(fr)
|
2009-07-24 |
2013-02-27 |
Amazentis Sa |
Composés, compositions et méthodes de protection de la santé du cerveau en cas de troubles neurodégénératifs
|
|
US9890195B2
(en)
*
|
2009-07-27 |
2018-02-13 |
Purdue Research Foundation |
MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
|
|
JP6339371B2
(ja)
|
2011-03-03 |
2018-06-06 |
インペル ニューロファーマ インコーポレイテッド |
経鼻薬物送達デバイス
|
|
BR112013026313A8
(pt)
|
2011-04-12 |
2018-01-30 |
Moerae Matrix Inc |
composições e métodos para prevenir ou tratar doenças, condições ou processos caracterizados por proliferação anormal de fibroblastos e depósito de matriz extracelular
|
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
EP2701712B1
(fr)
|
2011-04-25 |
2017-06-21 |
Cornell University |
Utilisation d'uridine et de désoxyuridine pour traiter les pathologies répondant aux folates
|
|
CN103619485B
(zh)
|
2011-05-09 |
2017-08-08 |
英倍尔药业股份有限公司 |
用于鼻腔药物递送的喷嘴
|
|
EP2589381B1
(fr)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions pour améliorer ou préserver une fonction de poumons chez un patient souffrant de troubles pulmonaires
|
|
WO2013134636A1
(fr)
|
2012-03-09 |
2013-09-12 |
Purdue Research Foundation |
Compositions et procédés d'administration de peptides inhibiteurs de kinases
|
|
DK2892524T3
(da)
|
2012-09-04 |
2021-01-25 |
Eleison Pharmaceuticals LLC |
Forebyggelse af pulmonalt kræfttilbagefald med lipid-komplekseret cisplatin
|
|
EP2991713B1
(fr)
|
2013-04-28 |
2019-06-19 |
Impel Neuropharma Inc. |
Récipient à dose unitaire médical
|
|
WO2015006639A1
(fr)
|
2013-07-12 |
2015-01-15 |
SILVA, John, H. |
Pièce buccale pour inhalateur
|
|
KR102300576B1
(ko)
|
2013-09-10 |
2021-09-08 |
보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 |
절단된 선종성 결장 폴립증 (ａｐｃ) 단백질을 타겟화하는 치료제
|
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
|
USD748242S1
(en)
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
|
CN107106650A
(zh)
|
2014-11-17 |
2017-08-29 |
莫伊莱麦屈克斯公司 |
用于预防或治疗表征为异常的成纤维细胞增殖和细胞外基质沉积的疾病、状况或过程的组合物和方法
|
|
WO2016092378A1
(fr)
|
2014-12-10 |
2016-06-16 |
Angelo Luigi Vescovi |
Procédés et compositions de réduction de la croissance, de la migration et du caractère invasif des cellules souches du cancer du cerveau, et d'amélioration de la survie de patients atteints de tumeurs du cerveau
|
|
EP3242886A4
(fr)
|
2015-01-08 |
2018-08-29 |
Moerae Matrix, Inc., |
Formulation de peptides inhibiteurs de mk2
|
|
JP2018512401A
(ja)
|
2015-03-12 |
2018-05-17 |
モイライ マトリックス インコーポレイテッド |
Ｍｋ２阻害剤ペプチド含有組成物を用いた非小細胞肺癌の治療を目的とするその使用
|
|
EP3307069B1
(fr)
|
2015-06-10 |
2021-08-04 |
Hackensack University Medical Center |
Utilisation du telmisartan pour la prévention et le traitement de la maladie du greffon contre l'hôte et d'autres maladies auto-immunes et allo-immunes
|
|
CN107949279A
(zh)
|
2015-07-06 |
2018-04-20 |
得克萨斯系统大学评议会 |
可用作用于治疗人类癌症的抗癌剂的苯甲酰胺或苯扎明化合物
|
|
CA2991420A1
(fr)
|
2015-07-15 |
2017-01-19 |
The Board Of Regents Of The University Of Texas System |
Ciblage de proteine de liaison de l'emopamil (ebp) avec de petites molecules qui induisent une reponse de retroaction anormale par l'abaissement de la biosynthese du cholesterol endogene
|
|
MX2018002895A
(es)
|
2015-09-10 |
2018-07-06 |
Impel Neuropharma Inc |
Dispositivo de administracion nasal en linea.
|
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
AU2017210319A1
(en)
|
2016-01-20 |
2018-08-23 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
|
EP3713626A4
(fr)
|
2017-11-21 |
2021-08-18 |
Impel Neuropharma Inc. |
Dispositif intra-nasale avec interface d'entrée
|
|
WO2019104205A1
(fr)
|
2017-11-21 |
2019-05-31 |
Impel Neuropharma, Inc. |
Dispositif intra-nasal avec tube plongeur
|
|
JP7317020B2
(ja)
|
2018-01-05 |
2023-07-28 |
インペル ファーマシューティカルズ インコーポレイテッド |
精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達
|
|
BR112020013750A8
(pt)
|
2018-01-05 |
2022-10-18 |
Impel Neuropharma Inc |
Dispensação intranasal de olanzapina por dispositivo olfativo de precisão
|
|
US11517548B2
(en)
|
2018-07-19 |
2022-12-06 |
Impel Pharmaceuticals Inc. |
Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
|
|
WO2020142206A1
(fr)
|
2019-01-03 |
2020-07-09 |
Impel Neuropharma, Inc. |
Dispositif d'administration de médicament par voie nasale
|
|
CN114025816A
(zh)
|
2019-05-17 |
2022-02-08 |
英倍尔药业股份有限公司 |
一次性鼻腔给送装置
|